What’s New at EA
RNA-Seq Grant Announcement
January 27, 2012
Thank you all for submitting your application, we had an overwhelming response. Because of this, we will need to extend our review process and now anticipate announcing the three grantees late June.
EA to Host Monthly Webinar Series
July 28, 2011
EA will host a series of webinars to help researchers gain insight into emerging DNA sequencing applications – “Best Practices for Emerging Applications in Next Generation Sequencing.”
Click here to register
EA Launches PacBio Services
July 6, 2011
EA has begun offering sequencing services on Pacific BioSciences’ PacBio RS system. EA is the first commercial service provider to offer sequencing on this platform and PacBio has selected EA to be their recommended North American commercial service provider. EA was chosen as a recommended service provider because of our deep expertise with new and emerging genomic technologies. Initial applications will include de novo and hybrid assembly, pathogen identification and targeted resequencing. Learn more about the technology
RNA-Seq Services
July 6, 2011
RNA sequencing has gained much interest due to the potential performance benefits relative to gene expression microarrays. The expected advantages include unbiased content, more precise quantification, detection of novel isoforms, and detection of nucleotide variation. Each of these measures is dependent on the read length, number of reads generated, and other factors that comprise the sequencing strategy. When it comes to expression, Expression Analysis is the proven leader. EA consistently achieves >100M PF clusters per lane* and greater than 95% alignment**. EA & RNA-Seq will help you detect 2x more differentially expressed transcripts and novel isoforms and SNVs. In addition EA will help you make sense of the data with over 10 years experience with expression. Learn more about our RNA-Seq Services
* Illumina TruSeq with v2 cluster generation protocol
**Typical results on human samples
Genomic Know-How™
January 15, 2011
Discovery is all about pushing the boundaries of what’s possible. That’s why Expression Analysis® harnesses hundreds of years of collective industry experience into something we call Genomic Know-How™. For you, this means access to experts. For your research, it means the best chance to breakthrough. From industry-leading experimental design, expression profiling, genotyping and sequencing to advanced bioinformatics and everything in between, no one takes your specimens more seriously.
Fully-Funded GWAS Grant
October 12, 2010
Expression Analysis and Illumina combine forces to offer a fully-funded GWAS Grant. The Grant includes up to 600 specimens as well as data analysis at absolutely no cost to you!
Two innovators—better than one!
May 20, 2010
Expression Analysis and Pacific Biosciences have partnered to bring the pharmaceutical industry breakthrough technology—Resequencing, De Novo Whole Genome Sequencing, and Viral Sequencing for infectious diseases will soon be available. As the recommended service partner for the pharmaceutical industry, Expression Analysis is uniquely positioned to provide access to these and more revolutionary sequencing applications. And, in the near future, single molecule real time detection will become a reality. Be one of the first to experience a partnership that puts your research first.